BRCA2 and neoplasm: Notably, this form of HUWE1-mediated resistance appeared to be particular to tumour cells with BRCA1 exon 11 truncating mutations that are able to express the BRCA1-∆11q protein and was not seen, for example, in tumour cells with BRCA1 exon 22 mutations or in BRCA2 mutant cells.